Breast cancer
Studying Quality of life and adverse effects in Hormone receptor positive/ HER2 negative Stage IV Breast cancer patients receiving CDK 4/6 inhibitor drugs with Hormonal therapy
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyStudy of how care is given
What it testsSee the registry
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 3 Feb 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Goa Medical College and Hospital, GoaGoa, GoaDirections ↗
Registry summary (technical)
A study of CDK4/6 inhibitors in combination with Hormonal therapy in ER+/HER2 negative metastatic Breast Cancer patients - NIL
Sponsor: Department of Medical Oncology, Goa Medical College, Bambolim, Goa
CTRI/2024/10/075989 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Feb 2025 · read by us 5 Nov 2026